Differentiation of stem-like CD4 + T cells modulates early effector responses in colorectal cancer
Strategies to improve cancer immunotherapy have largely focused on the intratumor immunosuppressive microenvironment, whereas approaches to amplify peripheral T cells and promote tumor recruitment have not been thoroughly explored. Using imaging mass cytometry in patients with colorectal cancer (CRC), we observed T helper 1 (T H 1)–like immune architectures in mismatch repair–deficient tumors associated with response to anti–programmed cell death protein 1 (PD-1) immunotherapy. By contrast, mismatch repair–proficient (pMMR) tumors showed regulatory T–dominant spatial interactions. Clonal analyses revealed that stem-like CD4 + T cells differentiated into T H 1-like cells after PD-1 blockade. In pMMR CRC mouse models, combined OX40 agonist and PD-1 blockade suppressed tumor progression by expanding Il7r + early effector CD4 + intermediates in tumor-draining lymph nodes, promoting migration and connection with T H 1-like cells. This was accompanied by interferon-γ–dependent induction of immunostimulatory monocyte-macrophages and CD8 + effector T cells. These findings suggest that leveraging peripheral CD4 + T cell amplification may improve immunotherapy responses.
Authors
- Chengqian Yin (ORCID: https://orcid.org/0000-0003-4247-6245)
- 程德春
- Jixing Zhong (ORCID: https://orcid.org/0000-0002-1511-8664)
- Guoxin Li (ORCID: https://orcid.org/0000-0003-2773-7048)
- Liying Zhao (ORCID: https://orcid.org/0000-0002-3723-5626)
- Yihong Wan (ORCID: https://orcid.org/0000-0003-0556-7017)
- Yi Wang (ORCID: https://orcid.org/0000-0002-8235-2952)
- Lei Zhang (ORCID: https://orcid.org/0000-0001-5589-5380)
- Xinhua Chen (ORCID: https://orcid.org/0000-0002-1879-4318)
- Hu Nie (ORCID: https://orcid.org/0000-0003-1240-4419)
- Haijun Deng
- Peilu Lin (ORCID: https://orcid.org/0009-0008-7647-7338)
- Zixuan Dai (ORCID: https://orcid.org/0009-0007-5737-6331)
- Zhijun Xu
- Zhen Liu
- Yu Zhang (ORCID: https://orcid.org/0009-0008-0564-3052)
- Cong Ouyang
- Yikang Chen
- Qiushuang Wu
Institutions
- Hong Kong University of Science and Technology (HK)
- Peking University (CN)
- Westlake University (CN)
- Shenzhen Bay Laboratory (CN)
- Nanfang Hospital (CN)
- Beijing Tsinghua Chang Gung Hospital (CN)
- Shenzhen Medical Academy of Research and Translation (CN)
- Southern Medical University (CN)
- South China University of Technology (CN)
- Tsinghua University (CN)
Publication Details
- Journal
- Science
- Published
- 2026-11-12
- DOI
- https://doi.org/10.1126/science.ady7788
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- Shenzhen Science and Technology Innovation Program
- Basic and Applied Basic Research Foundation of Guangdong Province